Home Conference Coverage

Conference Coverage

ASCO 2018

Chest 2019

syringe pushed into medical vial stopper on black background

Itacitinib Plus Corticosteroids for Chronic GVHD

cyclophosphamide molecular formula

PTCy, Abatacept, and Tacrolimus for GVHD Prophylaxis

Baricitinib vial with syringe in clean tray

Baricitinib Plus Standard GVHD Prophylaxis: Phase 1 Results

doctor with patient in office explaining survey

The Lasting Impact of Surviving Severe aGVHD

Venetoclax Resulted in High Efficacy in Patients With CLL With TP53 Disruption

Chronic lymphocytic leukemia (CLL) blood smear under light microscopy

More Than 20% of Patients With CLL Developed at Least 1 Second Primary Malignancy

Oral Anticancer Agent Therapy Adherence in Patients With CLL and Multiple Chronic Conditions

Oral Anticancer Agent Therapy Adherence in Patients With CLL and Multiple Chronic Conditions

Clinical Outcomes and Management of COVID-19 in Patients With CLL

Clinical Outcomes and Management of COVID-19 in Patients With CLL

Load more
Subscribe to RSS